NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FORECAST 2019-2027

NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FORECAST 2019-2027

The global exosome diagnostic and therapeutic market by North America was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 27.53% during the forecast period of 2019-2027. Exosomes are nano-sized vesicles that are secreted from specific cells and are known to be present in all kinds of biological fluids, such as the blood and urine.

NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET FORECAST 2019-2027

North America Exosome Diagnostic and Therapeutic Market by Application (Diagnostic, Therapeutic) by Product (Instrument, Reagent, Software) by End-user (Cancer Institute, Hospital, Diagnostic Center, Other End-user) by Geography.

Request free sample

Exosomes are nano-sized vesicles that are secreted from specific cells and are known to be present in all kinds of biological fluids, such as the blood and urine. The cases of fusion of multi-vesicular bodies with the cells through the plasma membrane trigger the secretion of exosomes.

The exosome diagnostic and therapeutic market defined in the report supplies the medical devices utilized in the exosome-based research activities for investigating the use of exosomes for the treatment of various types of diseases, for instance, cancer, cardiac diseases, and other chronic diseases. Their uptake have increased the most by the healthcare and research professionals since the diagnosis through the said reagents and instruments reveal rapid direction for almost accurate diagnosis of any respective diseases.

The global exosome diagnostic and therapeutic market by North America was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 27.53% during the forecast period of 2019-2027.

Higher frequency of occurrence of a variety of cancer plays a crucial role in the market expansion in North America. The regional market accounted for the major share of XX% of the global exosome diagnostic and therapeutic market and is expected to maintain this trend during the forecast period. The exosome diagnostics and therapeutics market in the region have witnessed significant growth in recent years and is expected to maintain this trend during the forecast period.

Rising incidence and prevalence of diseases coupled with the enlarging geriatric population are the major driving factors for the growth of the exosome diagnostic and therapeutic market in North America. The market in the region is characterized by the presence of a huge number of suppliers, vacillating from local to international suppliers. Due to the abundance of suppliers, buyers are majorly expected to switch from one to another supplier.

EVOX Therapeutics Ltd., Hitachi Chemical Diagnostics, Inc., Aethlon Medical, Inc., Qiagen N.V., System Biosciences (SBI), Nanosomix Inc., Sistemic Ltd., Codiak BioSciences, Malvern Instruments Ltd., Capricor Therapeutics, Inc., BioCat GmbH, HansaBioMed Life Sciences Ltd. (acquired by Lonza), Exosome Diagnostics Inc., Thermo Fisher Scientific Inc., and MBL International Corporation are the key companies that are mentioned in the report.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP-DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
        • DIAGNOSTIC IS THE MAJORLY USED APPLICATION
        • SOFTWARE SEGMENT IS ANTICIPATED TO GROW AT A SIGNIFICANT RATE
        • CANCER INSTITUTES HOLD THE LARGEST MARKET SHARE IN TERMS OF END-USER
    1. MARKET DYNAMICS
      • MARKET SCOPE & DEFINITION
      • MARKET DRIVERS
        • INCREASE IN PERVASIVENESS OF CANCER
        • RISING GOVERNMENT AND NON GOVERNMENT INITIATIVES
        • ADVANCEMENT IN TECHNOLOGY
      • MARKET RESTRAINTS
        • CHALLENGES FACED IN THE USAGE OF EXOSOME
        • STRINGENT REGULATION
      • MARKET OPPORTUNITIES
        • INCREASE IN ADOPTION OF INNOVATIVE AND ADVANCED EXOSOME DIAGNOSTIC AND THERAPEUTIC PROCEDURES
      • MARKET CHALLENGES
        • LOW AWARENESS IN THE DEVELOPING COUNTRIES
    1. MARKET BY APPLICATION
      • DIAGNOSTIC
      • THERAPEUTIC
    2. MARKET BY PRODUCT
      • INSTRUMENT
      • REAGENT
      • SOFTWARE
    3. MARKET BY END-USER
      • CANCER INSTITUTE
      • HOSPITAL
      • DIAGNOSTIC CENTER
      • OTHER END-USER
    4. KEY ANALYTICS
      • PORTER’S FIVE FORCES MODEL
        • THREAT OF NEW ENTRANTS
        • THREAT OF SUBSTITUTE
        • BARGAINING POWER OF BUYERS
        • BARGAINING POWER OF SUPPLIERS
        • THREAT OF COMPETITIVE RIVALRY
      • EXOSOME ETYMOLOGY
      • PATENT ANALYSIS
      • COMPONENTS OF EXOSOME
      • OPPORTUNITY MATRIX
    5. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • THE UNITED STATES
        • CANADA
    1. COMPETITIVE LANDSCAPE
      • COMPANY PROFILES
        • AETHLON MEDICAL, INC.
        • BIOCAT GMBH
        • CAPRICOR THERAPEUTICS, INC.
        • CODIAK BIOSCIENCES
        • EVOX THERAPEUTICS LTD.
        • EXOSOME DIAGNOSTICS INC.
        • HANSABIOMED LIFE SCIENCES LTD. (ACQUIRED BY LONZA)
        • HITACHI CHEMICAL DIAGNOSTICS, INC.
        • MALVERN INSTRUMENTS LTD.
        • MBL INTERNATIONAL CORPORATION
        • NANOSOMIX INC.
        • SISTEMIC LTD.
        • SYSTEM BIOSCIENCES (SBI)
        • THERMO FISHER SCIENTIFIC INC.
        • QIAGEN N.V.

LIST OF TABLES

TABLE 1        NOMENCLATURE OF EXOSOME PARTICLES

TABLE 2        NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

TABLE 3        NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 4        NORTH AMERICA DIAGNOSTIC MARKET 2019-2027 ($ MILLION)

TABLE 5        NORTH AMERICA THERAPEUTIC MARKET 2019-2027 ($ MILLION)

TABLE 6        NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY PRODUCT 2019-2027 ($ MILLION)

TABLE 7        NORTH AMERICA INSTRUMENT MARKET 2019-2027 ($ MILLION)

TABLE 8        COMMERCIAL KITS AND REAGENTS EXAMPLES FOR THE ISOLATION OF EXOSOME

TABLE 9        NORTH AMERICA REAGENT MARKET 2019-2027 ($ MILLION)

TABLE 10      NORTH AMERICA SOFTWARE MARKET 2019-2027 ($ MILLION)

TABLE 11      NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 12      NORTH AMERICA CANCER INSTITUTE MARKET 2019-2027 ($ MILLION)

TABLE 13      NORTH AMERICA HOSPITAL MARKET 2019-2027 ($ MILLION)

TABLE 14      EXOSOME ASSOCIATED PROTEIN IN CLINICAL DIAGNOSTICS USAGE

TABLE 15      NORTH AMERICA DIAGNOSTIC CENTER MARKET 2019-2027 ($ MILLION)

TABLE 16      NORTH AMERICA OTHER END-USER MARKET 2019-2027 ($ MILLION)

TABLE 17      TYPE OF PROTEINS FOUND IN EXOSOMES

TABLE 18      NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)

LIST OF FIGURES

FIGURE 1      NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 2      NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY APPLICATION 2018 & 2027 (%)

FIGURE 3      NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC 2019-2027 ($ MILLION)

FIGURE 4      NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY THERAPEUTIC 2019-2027 ($ MILLION)

FIGURE 5      NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY PRODUCT 2018 & 2027 (%)

FIGURE 6      NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY INSTRUMENT 2019-2027 ($ MILLION)

FIGURE 7      NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY REAGENT 2019-2027 ($ MILLION)

FIGURE 8      NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY SOFTWARE 2019-2027 ($ MILLION)

FIGURE 9      NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY END-USER 2018 & 2027 (%)

FIGURE 10   NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY CANCER INSTITUTE 2019-2027 ($ MILLION)

FIGURE 11   NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY HOSPITAL 2019-2027 ($ MILLION)

FIGURE 12   NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC CENTER 2019-2027 ($ MILLION)

FIGURE 13   INCIDENCE OF PATIENTS WITH CHRONIC DISEASES NORTH AMERICALY 2005-2030 (MILLIONS)

FIGURE 14   NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET BY OTHER END-USER 2019-2027 ($ MILLION)

FIGURE 15   PORTER’S FIVE FORCE MODEL

FIGURE 16   NUMBER OF PAPERS PUBLISHED ON EXOSOME 2003-2017

FIGURE 17   THE UNITED STATES EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

FIGURE 18   CANADA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY APPLICATION
    • DIAGNOSTIC
    • THERAPEUTIC
  2. MARKET BY PRODUCT
    • INSTRUMENT
    • REAGENT
    • SOFTWARE
  3. MARKET BY END-USER
    • CANCER INSTITUTE
    • HOSPITAL
    • DIAGNOSTIC CENTER
    • OTHER END-USER

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now